Jenny Yip

Jenny is currently serving as the Chief Operating Officer and Chief Investment Officer of a soon-to-launch healthcare startup with the vision to merge the for-profit and non-profit worlds in funding science for all. Previously, she was a Managing Partner at Adjuvant Capital, a life sciences investment fund dedicated to mid- to late-stage research and development of products addressing significant global health challenges affecting lower- and middle-income countries. In that role, Jenny served on numerous boards including Antiva Biosciences (US), 54gene (Nigeria), ChromaCode (US), Evofem Biosciences (US), and as a board observer on Excision Biotherapeutics (US).

Prior to Adjuvant, Jenny was a Partner at the Bill & Melinda Gates Foundation Strategic Investment Fund where she led transactions across the foundation’s focus areas in global health, agriculture, nutrition, and education. She has always been passionate about improving the health and lives of those living in low- resourced settings and spent time working in Kenya and China. In Kenya, Jenny was a volunteer consultant for Technoserve, a non-profit business consultancy for small-holder farmers and small to medium businesses.

Jenny has worked in finance for over 20 years, beginning as an investment banker advising corporate clients in mergers and acquisitions and debt and equity financings at Goldman Sachs’ Hong Kong, New York, and San Francisco offices. In her non-profit work, she serves on the boards of ReSurge International, the Global Fund for Women, the Hamlin School and on the Advisory Board of the Harvard Public Health Magazine.